Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

expert roundtables

What Drives the Choice Between Systemic Drugs in the Treatment of Plaque Psoriasis?

What Drives the Choice Between Systemic Drugs in the Treatment of Plaque Psoriasis?

expert roundtables
By Boni E. Elewski, MD; Bruce E. Strober, MD, PhD, FAAD; Steven R. Feldman, MD, PhD

$Therapeutic Sequencing in Relapsed/Refractory Diffuse Large B-Cell Lymphoma$

Therapeutic Sequencing in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

Investigational and Emerging Therapies for Diffuse Large B-Cell Lymphoma

Investigational and Emerging Therapies for Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

Chronic Graft-versus-Host Disease: Updates on Treatment and Prevention

Chronic Graft-versus-Host Disease: Updates on Treatment and Prevention

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); Daniel R. Couriel, MD, MS; Sergio A. Giralt, MD

Chronic Graft-versus-Host Disease: Management and Monitoring Recommendations

Chronic Graft-versus-Host Disease: Management and Monitoring Recommendations

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); Daniel R. Couriel, MD, MS; Sergio A. Giralt, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?